Holder evidence
6
SEC ownership of DA32 Life Science Tech Acquisition Corp.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001863294.
Lead holder
Section 32 Fund 3, LP
13D/G signal
—
Latest evidence
28 Jul 2023
- CIK
- 0001863294
- Location
- New York, NY
- SEC evidence mix
- 3/4/5
- Lead holder
- Section 32 Fund 3, LP
- Latest evidence date
- 28 Jul 2023
Issuer identity
2 facts
Ownership snapshot
3 facts
Ownership snapshot
Top shareholders of DA32 Life Science Tech Acquisition Corp. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Section 32 Fund 3, LP
13D/G signal
—
Evidence rows
6
Latest as of
28 Jul 2023
3/4/5
Highest disclosed value: $93,600,000
Rank 1 holder
Section 32 Fund 3, LP
3/4/5
- Ownership
- —
- Position
- $93.6M
Rank 2 holder
DA32 Sponsor LLC
3/4/5
- Ownership
- —
- Position
- $44.65M
Rank 3 holder
ARCH Venture Fund XI, L.P.
3/4/5
- Ownership
- —
- Position
- $6.5M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Section 32 Fund 3, LP |
3/4/5
Director, Director by Deputization, 10%+ Owner
|
—
class O/S missing
|
$93,600,000
9,360,000 shares
|
— | 05 Aug 2021 |
| DA32 Sponsor LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$44,650,000
4,465,000 shares
|
— | 05 Aug 2021 |
| ARCH Venture Fund XI, L.P. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$6,500,000
650,000 shares
|
— | 28 Jul 2023 |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
3/4/5
Director, Director by Deputization, 10%+ Owner
|
—
class O/S missing
|
$6,500,000
650,000 shares
|
— | 28 Jul 2023 |
| Keith Crandell |
3/4/5
Director, 10%+ Owner
|
—
class O/S missing
|
$6,500,000
650,000 shares
|
— | 28 Jul 2023 |
| Chris Wolfe |
3/4/5
Chief Financial Officer
|
—
class O/S missing
|
$1,250,000
125,000 shares
|
— | 05 Aug 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 01 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-12 of 12 reporting-owner rows connected to DA32 Life Science Tech Acquisition Corp.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
12
Lead holder
Section 32 Fund 3, LP
Net 12M change
$0
Latest report
28 Jul 2023
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Section 32 Fund 3, LP | Director, Director by Deputization, 10%+ Owner | $93,600,000 | Mixed | 05 Aug 2021 | ||
| DA32 Sponsor LLC | 10%+ Owner | $44,650,000 | Mixed | 05 Aug 2021 | ||
| Keith Crandell | Director, 10%+ Owner | $6,500,000 | Mixed | 28 Jul 2023 | ||
| ARCH Venture Fund XI, L.P. | 10%+ Owner | $6,500,000 | Mixed | 28 Jul 2023 | ||
| DEERFIELD MANAGEMENT COMPANY, L.P. | Director, Director by Deputization, 10%+ Owner | $6,500,000 | Mixed | 28 Jul 2023 | ||
| Chris Wolfe | Chief Financial Officer | $1,250,000 | Mixed | 05 Aug 2021 | ||
| Nicolas H. Roelofs PhD | Director | Mixed | 27 Jul 2021 | |||
| Andrew ElBardissi | Director | Mixed | 27 Jul 2021 | |||
| Angela Lai | Director | Mixed | 27 Jul 2021 | |||
| Steven J. Kafka | Chief Executive Officer, Director | Mixed | 27 Jul 2021 | |||
| E. Kevin Hrusovsky | Director | Mixed | 27 Jul 2021 | |||
| Mara G. Aspinall | Director | Mixed | 27 Jul 2021 |
Recent insider transactions for DA32 Life Science Tech Acquisition Corp.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Reported value | Reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* indicates a reported price that failed the local validity check.